ProQR Therapeutics is a NASDAQ-listed biotechnology company headquartered in Leiden, the Netherlands, with an office in Cambridge, Massachusetts, USA, developing innovative RNA-editing medicines through its proprietary Axiomer platform. Our mission is to edit RNA, treat disease
Sherwood Pharmaceuticals is a young startup exploring the first-ever treatment for Cri du Chat syndrome, a rare genetic disease. At Sherwood Pharmaceuticals we are assessing a drug repurposing opportunity for the potential treatment of Cri du